Compare KARD & ELVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KARD | ELVR |
|---|---|---|
| Founded | 2023 | 2000 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2026 | 2018 |
| Metric | KARD | ELVR |
|---|---|---|
| Price | $14.10 | $22.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $41.00 | N/A |
| AVG Volume (30 Days) | ★ 577.7K | 49.1K |
| Earning Date | 11-22-2026 | 10-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $45.49 |
| Revenue Next Year | $50.00 | $12.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.23 | $21.32 |
| 52 Week High | $27.00 | $102.80 |
| Indicator | KARD | ELVR |
|---|---|---|
| Relative Strength Index (RSI) | 47.93 | 23.99 |
| Support Level | $13.75 | N/A |
| Resistance Level | $15.93 | $57.48 |
| Average True Range (ATR) | 0.99 | 1.14 |
| MACD | 0.32 | 0.29 |
| Stochastic Oscillator | 68.52 | 9.25 |
Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.
Elevra Lithium Ltd is a mineral exploration and development company. The principal activity of the company is lithium mining and processing at North American Lithium(NAL) and ongoing identification, evaluation and development of its world-wide portfolio of mineral exploration assets, predominantly focusing on lithium. Its segments are North American Lithium, and All other operations. Majority of revenue comes from North American Lithium. It has presence in China, and USA. Majority of revenue comes from China.